TALS - Talaris Therapeutics, Inc. Stock Price, Fair Value and News

$2.72-0.02 (-0.73%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TALS Price Action

TALS RSI Chart

TALS Valuation

Market Cap

73.3M

Price/Earnings (Trailing)

-1.32

Price/Free Cashflow

-1.63

TALS Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TALS Fundamentals

TALS Revenue

TALS Earnings

Earnings (TTM)

-63.9M

Earnings Growth (Yr)

-260.88%

Earnings Growth (Qtr)

-15.38%

TALS Profitability

Return on Equity

-19.9%

Return on Assets

-19.45%

Free Cashflow Yield

-61.18%

TALS Investor Care

Shares Dilution (1Y)

26.09%

Diluted EPS (TTM)

18.68

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	0	0	0	0
2022	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR001 for the patients with a severe form of scleroderma. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Wellesley, Massachusetts.

CEO	Ms. Mary Kay Fenton
WEBSITE	https://talaristx.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	84

Talaris Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Talaris Therapeutics, Inc.? What does TALS stand for in stocks?

TALS is the stock ticker symbol of Talaris Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Talaris Therapeutics, Inc. (TALS)?

As of Thu Oct 31 2024, market cap of Talaris Therapeutics, Inc. is 73.34 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TALS stock?

You can check TALS's fair value in chart for subscribers.

Is Talaris Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether TALS is over valued or under valued. Whether Talaris Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Talaris Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TALS.